The feasibility of performing central lymph node dissection of the neck in the surgical treatment of benign thyroid disease
Clinical Endocrinology and Endocrine Surgery · 30.03.2026 · (1) · 5-11
DOI: 10.30978/cees-2026-1-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Endocrinology and Endocrine Surgery, online erschienen am 30.03.2026. Verfasst von O. A. Tovkai und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).
Abstract (Originalsprache)
Multinodular goiter and diffuse toxic goiter are common diseases of the thyroid gland. Most of them are benign, but the risk of malignancy is always present. Latent thyroid cancer presents certain diagnostic and therapeutic challenges, which emphasizes the need for a comprehensive study and treatment strategy. The role of prophylactic thyroid dissection remains a subject of discussion even in proven thyroid cancer cases. Objective — to determine and analyze the frequency of thyroid cancer in benign thyroid disease, including the presence of «incidental» thyroid cancers. To analyze the incidence of thyroid cancer metastases in cases of multi nodular goiter, with TBSRTC class II, III, throtoxicosis and the presence of specific complications of neck dissection. Materials and methods. Data from surgeries performed in 851 patients were analyzed. Among them, 774 (90.9%) patients had benign tumours, 77 (9.1%) were diagnosed with thyroid cancer.
Results
It was established that in subgroup I (TBSRTC ІІ, multi nodular goiter), thyroid cancer was detected in 10 (6.2%) patients, metastasis in regional lymph nodes in 1 (0.9%) patient. In subgroup II (TBSRTC ІІІ, multinodular goitre), thyroid cancer was detected in 14 (14.7%) patients, metastasis in regional lymph nodes in 3 (3.6%) patients. Among patients of subgroup III, thyroid cancer was recorded in 11 (5.9%)patients and in subgroup IV (graves disease) thyroid cancer was found in 42 (10.2%) cases, metastasis in regional lymph nodes in 4 (1.9%) patients. «Incidental» cancer was detected in 55 patients out of 851, which is 6.5%. Performing central neck lymphadenectomy did not lead to an increase in specific intraoperative complications.
Conclusions
The incidence of thyroid cancer in benign thyroid disease is 9.1%, locoregional metastasis was noted in 1.9% of cases. The obtained results of the study prove that neck lymphadenectomy may be appropriate for ensuring oncological radicalism and determination of risk stratification and further treatment tactics.
Zitieren
APA
Tovkai, O. A., Palamarchuk, V. O., Voitenko, V. V., Yatsiv, A. R., Lostik, Y. Y., Kuts, V. V., & Gybalo, R. V. (2026). The feasibility of performing central lymph node dissection of the neck in the surgical treatment of benign thyroid disease. Clinical Endocrinology and Endocrine Surgery, 5-11. https://doi.org/10.30978/cees-2026-1-5
Vancouver
Tovkai OA, Palamarchuk VO, Voitenko VV, Yatsiv AR, Lostik YY, Kuts VV, et al. The feasibility of performing central lymph node dissection of the neck in the surgical treatment of benign thyroid disease. Clinical Endocrinology and Endocrine Surgery. 2026:5-11. doi:10.30978/cees-2026-1-5
BibTeX
@article{Tovkai2026,
author = {Tovkai, O. A. and Palamarchuk, V. O. and Voitenko, V. V. and Yatsiv, A. R. and Lostik, Y. Y. and Kuts, V. V. and Gybalo, R. V.},
title = {The feasibility of performing central lymph node dissection of the neck in the surgical treatment of benign thyroid disease},
journal = {Clinical Endocrinology and Endocrine Surgery},
year = {2026},
number = {1},
pages = {5--11},
doi = {10.30978/cees-2026-1-5}
}
EUVIMED